GSK Settlement Of AWP “Spread” Case Includes Pricing Audits
This article was originally published in The Pink Sheet Daily
Executive Summary
Under a settlement with the Justice Department, GlaxoSmithKline will pay $150 mil. and expand compliance program training required by an existing corporate integrity agreement.
You may also be interested in...
Abbott’s Vancomycin “Spread” Is Target Of DoJ Suit
Ven-A-Care suit, taken up by Department of Justice, alleges Medicare and Medicaid paid an excess of $75 mil. for the antibiotic.
Abbott’s Vancomycin “Spread” Is Target Of DoJ Suit
Ven-A-Care suit, taken up by Department of Justice, alleges Medicare and Medicaid paid an excess of $75 mil. for the antibiotic.
California Sues 39 Firms For Reporting Inflated Prices To Medicaid
Wyeth is dropped from defendant list, but Amgen, GlaxoSmithKline, Bristol-Myers Squibb and Novartis are among firms joining original defendant Abbott.